Company News

Share this article:
Boehringer Ingelheim will buy much of Wyeth's Fort Dodge Animal Health business when Pfizer's acquisition of Wyeth closes. In the US and Canada, Boehringer Ingelheim would own and market Wyeth's pet and cattle vaccine lines as well as a range of drugs for pets, cattle and other species, including several swine vaccines in Canada.
Share this article:
close

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

Massachusetts painkiller ban overruled

A District Court says Massachusetts cannot ban opioid painkiller Zohydro.

Ranbaxy extends branded Diovan's life

Ranbaxy may be on the blocks, but it has a hold on the right to produce generics of the Novartis heart medication Diovan. Only problem: it can't, and that is good news for Novartis.

FDA approves Glaxo's GLP-1

Type-2 diabetes injection Tanzeum, also known as albiglutide, scored the approval Tuesday.